Gemini vitamin D analog represses the expression of a stem cell marker CD 44 in breast cancer

نویسندگان

  • Hong Jin Lee
  • Amanda K. Smolarek
  • Shiby Paul
  • Chung-Xiou Wang
  • Hubert Maehr
  • Milan Uskokovic
  • Xi Zheng
  • Allan H. Conney
  • Li Cai
  • Fang Liu
  • Nanjoo Suh
چکیده

Department of Chemical Biology, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA (J.Y.S., H.J.L., A.K.S., S.P., C.X.W., H.M., M.U., X.Z., A.H.C., F.L., N.S.); Department of Food Science and Technology, Chung-Ang University, Anseong 456-756, South Korea (H.J.L); Department of Biomedical Engineering, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA (L.C.); Center for Advanced Biotechnology and Medicine, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA (F.L.); The Cancer Institute of New Jersey, New Brunswick, NJ 08901, USA (X.Z., A.H.C., L.C., F.L., N.S.) Molecular Pharmacology Fast Forward. Published on November 29, 2010 as doi:10.1124/mol.110.068403

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

A novel Gemini vitamin D analog represses the expression of a stem cell marker CD44 in breast cancer.

CD44 is a multifunctional transmembrane protein involved in cell proliferation, angiogenesis, invasion, and metastasis. CD44 is identified as a cancer stem cell marker, and the CD44-positive breast cancer cells are enriched in residual breast cancer cell populations after conventional therapies, suggesting that CD44 may be an important target for cancer prevention and therapy. Therefore, we inv...

متن کامل

میزان بیان پروتئینBRCA1 در کارسینوم های مهاجم و درجای پستان و ارتباط آن با مارکر سلول های بنیادی سرطان پستان (CD44) و عوامل پیش آگهی تومور

  Introduction : Breast cancer is the most common cancer and the second cause of cancer death among women. Despite recent developments in therapeutic tools about 25% of all the involved cases die annually. The clinical, molecular, and pathologic features of breast cancer in BRCA1 mutation carriers suggest that BRCA1 may function as a stem-cell regulator. The purpose of the current study was to ...

متن کامل

The characterization of CD marker profile of breast milk-derived stem cell

Background  The mammary gland in humans is a dynamic organ that undergoes significant developmental changes during pregnancy, lactation, and involution. Stem cells derived from human breast milk possess the adult stem cell-like characteristics such as self-renewal, proliferative and differentiate potential. This source of stem cells avoids invasive procedures and the ethical controversy of emb...

متن کامل

Evaluation of Nucleostemin Gene Expression as a New Molecular Marker in Breast Tumors

Background & Aims: Nucleostemin is one of the stem cell enriched proteins which encodes a novel nucleolar GTP-binding protein found at high levels in the adult and embryonic stem (ES) cells but not in terminally differentiated cells. It is also expressed in tumor cell lines as well as in the several types of human cancers. Due to the increasing rate of breast cancer in recent years, in the pres...

متن کامل

Targeting CD44-STAT3 Signaling by Gemini Vitamin D Analog Leads to Inhibition of Invasion in Basal-Like Breast Cancer

BACKGROUND CD44, a transmembrane glycoprotein, is a major receptor for extracellular proteins involved in invasion and metastasis of human cancers. We have previously demonstrated that the novel Gemini vitamin D analog BXL0124 [1α,25-dihydroxy-20R-21(3-hydroxy-3-deuteromethyl-4,4,4-trideuterobutyl)-23-yne-26,27-hexafluro-cholecalciferol] repressed CD44 expression in MCF10DCIS.com basal-like hum...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2010